PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

Core Insights - PMV Pharmaceuticals, Inc. is a precision oncology company focused on developing small molecule, tumor-agnostic therapies that target p53, a protein associated with approximately half of all cancers [1][3]. Company Overview - PMV Pharma was co-founded by Dr. Arnold Levine, who discovered the p53 protein in 1979, establishing the field of p53 biology [3]. - The company combines extensive knowledge of p53 biology with a focus on pharmaceutical development [3]. - PMV Pharma is headquartered in Princeton, New Jersey [3]. Upcoming Events - PMV Pharma's management will participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, at 12:40 PM EST [2]. - The company will also attend the TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 3:10 PM EST [2]. - Live audio webcasts of these events will be available online, with archived replays accessible for 90 days [2].